Lorna Jane, an Australian activewear company, was recently fined AU$5 million after claiming that its new line of active clothing can stop the spread of COVID-19. The firm said that its clothing could eliminate the virus, thus preventing its spread.
According to BBC News, Lorna Jane released advertisements that say it is using a groundbreaking technology called LJ Shield for its clothing line. It was claimed that this could stop the "transfer of all pathogens."
What the court says on Lorna Jane’s claims
Based on the report, a judge said in a ruling that the company’s claim about LJ Shield is "exploitative, predatory and potentially dangerous." The legal action against Lorna Jane was filed by the Australian Competition & Consumer Commission (ACCC) after the firm started selling its clothing in July amid the COVID-19 pandemic.
The verdict was said to have been released by the federal court on Friday, July 23. The judge said that based on investigations, Lorna Jane has been telling the consumers it has a “reasonable scientific or technological basis" for its claims about its clothing with the LJ Shield.
However, the judge said there was actually no scientific basis for such a claim. For this false and misleading representation to the public, the court slapped the company with a hefty fine.
"This was dreadful conduct as it involved making serious claims regarding public health when there was no basis for them," chairman of the ACCC, Rod Sims, said. "The whole marketing campaign was based upon consumers' desire for greater protection against the global pandemic."
Lorna Jane accepts the judge’s decision
The company was said to have accepted the verdict but explained, it was also misled by its supplier. Lorna Jane claimed its supplier sold them a product that did not deliver what it claimed to be, and they are referring to what they called the LJ Shield technology that is supposed to be anti-viral and anti-bacterial.
Meanwhile, it was learned that this is not the first time that Lorna Jane was fined. As per The Guardian, just in July 2020, the company was fined $40,000 for its failure to seek proper approval for ads from the Therapeutic Goods Administration. As for this new issue, the company issued an apology for its customers while continuing to blame its supplier for the issue.


Air Canada Express Plane Collides with Ground Vehicle at LaGuardia Airport
Palantir's Maven AI Earns Pentagon "Program of Record" Status, Reshaping Military AI Strategy
J.P. Morgan Now Expects Two ECB Rate Hikes Amid Inflation Pressures
Elon Musk Announces Terafab: SpaceX and Tesla to Build Dual AI Chip Factories in Austin, Texas
South Korean Stocks Tumble as Hawkish BOK Governor Appointment Rattles Markets
Saudi Arabia Warns Oil Prices Could Surge Past $180 a Barrel Amid U.S.-Israel-Iran Conflict
Iran-Israel War Escalates: Long-Range Missiles, Nuclear Site Strikes, and Global Energy Crisis
SLMG Beverages Eyes Price Hikes Amid Rising Packaging Costs and India's Booming Soft Drink Market
Japan Eyes Reduction in Inflation-Linked Bond Buybacks Amid Surging Investor Demand
Israel Defies Trump's Warning, Launches New Strikes on Iran Amid Growing Global Energy Crisis
Iran-U.S. War Sends Dollar Higher as Middle East Tensions Escalate
Goldman Sachs Delays Bank of England Rate Cut Forecast Amid Middle East Inflation Risks
Oil Prices Surge Amid Trump's Iran Ultimatum Over Strait of Hormuz
NVIDIA's Feynman AI Chip May Face Redesign Amid TSMC Capacity Crunch
U.S. Markets Post Fourth Straight Weekly Loss Amid Middle East Escalation
Elliott Investment Management Takes Multibillion-Dollar Stake in Synopsys
Volkswagen CEO Urges Germany to Adopt China's Industrial Discipline Amid Major Restructuring 



